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Abstract: Extracellular vesicles (EVs) actively participate in intercellular communication and pathological processes. Studying the molecular signatures of EVs is key to reveal their biological functions and clinical values,w hich, however, is greatly hindered by their sub-100 nm dimensions,t he low quantities of biomolecules each EV carries,a nd the large population heterogeneity.N ow,s ingle-EV flow cytometry analysis is introduced to realizes ingle EV counting and phenotyping in aconventional flowcytometer for the first time, enabled by target-initiated engineering (TIE) of DNAn anostructures on each EV.B yi lluminating multiple markers on single EVs,s tatistically significant differences are revealed among the molecular signatures of EVs originating from several breast cancer cell lines,and the cancer cell-derived EVs among the heterogeneous EV populations are successfully recognized. Thus,o ur approachh olds great potential for various biological and biomedical applications.
Extracellular vesicles (EVs) are membrane-encapsulated vesicles (30-100 nm) secreted by all cell types and present in various biological fluids.
[1] They constitute an emerging target for liquid biopsy in cancer diagnosis because they actively participate in cell-cell communication by shuttling signaling molecules between cells and modulate pathological processes such as tumor initiation, progression, and metastasis.
[2] Study of the molecular signature of EVs is thus critical for profoundly understanding their biological functions and clinical values.
[3] Existing methods for EV study are primarily focused on bulk analysis of al arge number of EVs,b ecause the small physical dimensions of EVs limit the total amounts of biomolecules to be carried in each EV,g reatly enhancing the difficulty in molecular profiling. [5] However, subtle molecular differences at the single EV level may yield significant variation in EV biological functions, [6] and the highly heterogeneous nature of EV population demands the development of techniques capable of profiling individual EVs. [4] Most recently,s ingle EV counting with an anochip [7] and imaging single vesicles with advanced fluorescence microscopy [8] have been reported, and showed that EVs from different cell of origin can carry distinct surface markers mimicking their parent cells.S till, they require EV immobilization steps,limiting the down-stream investigations on EV functions and biogenesis.
Flow cytometry has been widely employed to distinguish different cell types in mixed populations based on the expression of cellular markers. [9] Similarly,i tc ould be used to study the heterogeneous EVs.H owever,t he sizes of EVs fall well below the detection limit of conventional flow cytometers,m aking it impossible to do single-EV analysis without significant instrumentation development. [10] Herein, we report the first single-EV flow cytometry analysis (FCA) in conventional flow cytometers enabled by target-initiated engineering (TIE) of DNAnanostructures on individual EVs. This technique employs ac onformation-switchable DNA probe to bind to the EV surface marker,w hich triggers the engineering of aD NA nanostructure by hybridization chain reaction (HCR). [11] TheH CR products not only enlarge the overall size of the single EV to be beyond 500 nm, but also can bind to multiple fluorophores to amplify the signal from the few marker molecules locating on the limited area of EV surface,both enabling visualization of single EVs in aconventional flow cytometer,a nd greatly simplifying measurement of multiple markers on the same EV.
To test the working principle,wedesigned the conformation-switchable probe to recognize CD63, ac lassic tetraspanin marker that is highly abundant in various EVs (Figure 1A) . This probe contained at arget recognition domain with the sequence of an anti-CD63 aptamer [12] and at rigger domain for initiation of DNAg rowth via HCR. These two domains were flanked by ah inge sequence to achieve conformation change triggered by aptamer-target interaction ( Figure 1A ;Supporting Information, Table S1 ): apart of the target recognition domain hybridized with the trigger domain (that is,"deactivated state") to form ahairpin structure,which could be opened upon target binding to expose the sequence ("activated state") for hybridization with Hairpin 1( H1). Then sequential hybridization between H1 and H2 would occur to build the long dsDNAp roduct on EV ( Figure 1A ).
Thed esign of target-initiated engineering of DNAn anostructure could effectively eliminate non-specific DNA growth without the target. Furthermore,t he DNAn anostructures constructed upon recognition of the free,n on-EV bound target would not locate on EV surface and should not reach the size range detectible by the conventional flow cytometer.Both features significantly reduce the background in FCA and render our technique ultra-high simplicity:n o washing is necessary to remove the unreacted probes.
Successful DNAhybridization cascade initiated by CD63 or the CD63-containing EVs was verified by native agarose gel electrophoresis.W ec an see from the gel image (Figure 1B) t hat, long DNAp roducts were formed in the presence of CD63 protein (Lane 3), accompanied with significant consumption of H1 and H2, similar to the reaction between the hairpins and as imple initiator (Lane 2), as equence of the trigger domain that can directly hybridize with H1 without target recognition and initiate DNAgrowth. With the CD63-containing EVs (referred to as "standard EVs" hereafter), most of the long DNAp roducts were trapped inside the loading well probably by binding to the EVs (Lane 4). We employed transmission electron microscopy (TEM) to confirm the size enlargement in EVs produced by TIE. As clearly illustrated in Figure 1C ,a fter TIE, each standard EV exhibited the "hairy" morphology on its surface, with the overall size increasing from the original tens of nanometers to hundreds of nanometers and maintaining the spherical shape (Supporting Information, Figure S1 A,B). In contrast, the DNAhybridization products triggered by simple initiator were in random shapes without the densely stained core (Supporting Information, Figure S1 C). Theg rowth effect was also viewed by atomic force microscopy (AFM) (Supporting Information, Figure S2 ) and nanoparticle tracking analysis (NTA) Supporting Information, (Figure S1 D): after TIE, DNAs trands up to 250 nm long were seen surrounding the individual EVs under AFM;a nd the size distribution profile in NTAs hifted to the larger size region with anew peak at 500 nm appeared.
We examined the enlarged EVs by ac onfocal fluorescence microscope.L abeled the hairpins with biotin, the long DNAp roducts can be tagged with the streptavidin-conjugated fluorescent probes,l ike the Qdot 525 streptavidin conjugate (QDs,Ex488 nm/Em 525 nm) and the streptavidin/ rhodamine-conjugated iron oxide nanoparticles (RhNPs,E x 547 nm/Em 572 nm). These two tags were used to produce two distinct EV populations in separate reaction tubes,which were mixed and inspected under microscope.I ndeed, the engineered EVs labeled with either the QDs or the RhNPs were clearly discernible in the confocal mode with an objective of 40 ( Figure 1D ). We even found particles that were overlapped (highlighted by at riangle), located close to each other (highlighted by asquare), or completely separated (indicated by circles), showing that each fluorescent particle represented one individual vesicle.The negative controls,that is,t he QD-labeled DNAn anostructure established by the simple initiator,and the RhNPs or QDs by themselves,were not observable even under ah igher magnification of 60 or 100 (Supporting Information, Figure S3 ), which was due to the few numbers of QDs on each DNAn anostructure.O n contrary,e ach EV could carry multiple surface markers,a nd be labeled by multiple dsDNAs (Supporting Information, Figure S2 ) that not only enlarge the overall size,b ut also Compared to microscopic imaging,f low cytometry provides fast and automatic particle counting at the rate of thousands particles per second;a nd can sort pure particle populations defined by fluorescence patterns,m uch more ideal for interrogating single biological particles.T hus,w e explored whether the engineered EVs could be detected in aconventional flow cytometer FACSCanto that is widely used in research and clinical settings.A nalysis of the standard beads confirmed that this instrument could not see particles smaller than 500 nm. In this experiment, the DNAn anostructure carried by the engineered EVs were tagged by either Alexa Fluor 488 streptavidin conjugates (that is,E ngr. EVAlexa488) or the green QDs-525 (Engr.E V-QDs). Interestingly,b oth EV samples revealed as ignificant particle cluster in the flow cytometry plots of FSC (forward scatter) vs.S SC (side scatter) and FL1 (fluorescence channel, l ex = 488 nm) vs. SSC (Figure 2A ). These particles exhibited larger FSC and higher fluorescence (FL) than the background particles, confirming the significant EV size enlargement induced by the CD63-initiated EV engineering;and the signal amplification from the multiple fluorescent tags bound to the long DNAc hains on each EV.G ating the particle cluster by R1 (for the QD label) or R2 (for the Alexa488 label) illustrated that the enlarged EVs represented about 50 %o ft he total particles detected for each sample (Supporting Information, Table S2 ). In contrast, no distinct particle cluster was detected on the flow plots obtained from the negative control samples, including the EVs labeled by the anti-CD63-conjugated QDs without any size enlargement (that is,EV-QDs) (Figure 2A) , and the EVs mixed with just the hairpins and QDs (Supporting Information, Figure S4 ). Theb ackground particles present in Figure 2A and the Supporting Information, Figure S4 with low forward scatter and fluorescence signals might be produced from non-specific adsorption of the hairpins and QDs on the EVs,a sw ell as random aggregation of QDs in solutions.F urthermore,T IE on free CD63 did not produce observable particles,e nsuring the counting was from intact EVs instead of free markers released by cells or from vesicle breakage.
Using R1 and R2, we compared the scatter and FL signals obtained with Alexa488 and QDs ( Figure 2B ). Both labels gave out comparable FSC readings (the mean FSC intensity ratio of QD/Alexa = 0.92 AE 0.07 (n = 3)), indicating the size enlargement effect was mainly resulted from the growth of the dsDNA, not the additional size of the fluorescent tag. Labeling with QDs resulted in 70.5 AE 6.2 (n = 3) times higher FL than with Alexa488. Theh igher FL shifted the enlarged EVs further away from the background particles,making the population more distinct, which is acritical characteristic for future sorting of specific EV populations.This is the first time an ew population of detectible EVs appearing on the flow cytometric plots to enable clear and unambiguous recognition of pure EV population in ac onventional flow cytometer, owing to TIE-enabled transformation of the invisible EVs to the visible particles.
Thek inetics of TIE was studied by changing the HCR time from 0hto 24 h. Agate was applied on the flow plots to identify the particle cluster displaying higher FL and larger FSC than background, which were considered as the detectible events.W ef ound that, ar eaction time of 2hproduced only very few numbers of the detectible events,w hich dramatically increased at 4and 8h(Supporting Information, Figure S5 ). NTAm easurement also confirmed that with the reaction time increasing to 4a nd 8h,m ore engineered EVs larger than 250 nm were produced (Supporting Information, Figure S1D ). Them ean fluorescence intensity (MFI) gradually increased with the reaction time going from 0t o8h ( Supporting Information, Figures S5,S6) . However,extending the reaction to 12 hdid not induce significant changes in the number of detectible events and the MFI value detected in the flow cytometer,n either big change was observed in the size distribution profile obtained with NTA. This result indicates that recognition of the CD63-positive EVs may have reached asteady state and no new engineered EVs could be produced with longer reaction time.Still, the length of the DNAp roduct continued to increase with longer reaction duration, which generated the engineered EVs larger than 500 nm at 24 ho bserved by NTA( Supporting Information, Figure S1 D). However,s pace hindrance and winding of the long DNAs trand may have prevented more QDs from binding to the DNA; and after being kept at 37 8 8Cfor 24 h, the EVs may no longer be stable,both leading to the decrease in MFI and detectible events measured by flow cytometry (Supporting Information, Figure S6 ). While detailed study of the kinetics of engineering DNAn anostructures on EVs needs to be conducted in future works,t he present work employed overnight reaction to obtain stable signals in flow cytometric analysis of single EVs. Under the optimized TIE conditions,w ec onfirmed that the number of detectible events was linearly (R 2 = 0.9974) proportional to the number of EVs in the sample within the range of 20 mgmL À1 to 500 mgmL À1 (Supporting Information, Figure S7 ), proving the capability of our method in EV quantification. Furthermore,t he robustness of our method was verified by the intraday and interday replicates (Supporting Information, Table S3 ). TheS tudents t test obtained a p value smaller than 10 À4 when evaluating the MFI or mean forward scatter (MFS) among all these replicates,s howing that EV engineering is highly reproducible.More importantly, we showed that our method can directly engineer the EVs in biofluids such as cell culture medium (Supporting Information, Figure S8 ) and serum ( Supporting Information, Figure S9) by simply treating the matrix with sodium citrate to inhibit exonuclease activity. [13] Direct EV detection in biological samples with minimum sample pretreatment and without EV enrichment or immobilization is ab ig advancement compared to existing technologies and makes our method highly suitable for studying the heterogeneity of EV populations and examining their clinical values.
Differentiation of heterogeneous EVs requires recognition of multiple markers.T he TIE system can be easily adjusted to target different surface biomarkers by simply switching the aptamer sequence in the conformation-switchable DNAp robe.T od emonstrate this,w ed esigned another TIE system to target human epidermal growth factor receptor 2( HER2), at ypical breast cancer marker overexpressed in about 20 %ofbreast cancer patients and present on asubset of EVs derived from breast cancer cell lines. [14] We substituted the anti-CD63 aptamer with an anti-HER2 aptamer [15] in the target-recognition domain, and kept the trigger domain intact. Theh inge domain was adjusted slightly to achieve effective conformational switching upon HER2 recognition (Supporting Information, Table S1 ). Since the HCR triggered by HER2 remains the same as that by CD63, we define it as the "single hybridization cascade system", and applied it to analyze HER2 and CD63 expression separately on single EVs secreted by three different cell lines:the breast cancer cells of SKBR3 (highly metastatic) and MCF-7 (poorly metastatic) and the non-tumor epithelial cell MCF-10A. We found that the anti-HER2 system produced more detectable events from the SKBR3-derived EVs than those from MCF-7 and MCF-10A (Supporting Information, Figure S11 a) . Furthermore, two times more events were detected by the anti-HER2 system on the SKBR3 EVs than by the anti-CD63 system. On the other hand, the EVs originating from MCF-10A and MCF-7 resulted in comparable numbers of detectable events for detection of CD63 or HER2. These results agree well with the bulk analysis by ELISA ( Supporting Information, Figure S10) , which confirmed the overexpression of HER2 in SKBR3 cells as reported previously, [16] and found two times more HER2 than CD63 in the SKBR3-derived EVs,b ut comparable amounts of HER2 and CD63 in the EVs from MCF-7 and MCF-10A cells.
Interestingly,u sing the MFI and MFS values obtained from both markers as the four variables to conduct principal component analysis (PCA), the EVs from each cell line can be clearly differentiated by their cells of origin (Supporting Information, Figure S11 b) , hinting that the size and FL increase resulted from TIE can help to differentiate EV subpopulations.Ifthe signals from both markers can be acquired simultaneously,t he flow plots should directly show the presence of EV sub-populations in ah eterogeneous EV mixture without the help of statistical tools,which is necessary for single vesicle analysis using microscopic methods. [8] Herein, we designed ad ual hybridization cascade system to simultaneously amplify signals from HER2 and CD63 on as ingle EV by two separate hybridization cascade reactions (Supporting Information, Table S1 ). In this system, CD63 signal was still derived from the streptavidin-conjugated QDs, but HER2 signal was from the Alexa660 labeled DNAt ag hybridized with the overhang in H3 on the HCR product ( Figure 3B ;S upporting Information, Table S1 ). Thef luorescence of QDs and Alexa660 were detected in the FACSCanto fluorescence channel of FL1 and FL4, respectively.A s expected, the detectible events from the EVs produced by SKBR3, MCF-7, and MCF-10A located at distinct positions on the fluorescence flow cytometric plots,e ach EV subpopulation exhibiting characteristic distribution patterns ( Figure 3A ;S upporting Information, Figure S12 ). Viewing CD63 as the internal standard, we calculated the MFI ratio of FL4/FL1 to represent the relative content of HER2 and CD63 on the same EV.S ignificant difference in the MFI ratios between EVs from the MCF-10A and SKBR3 cells (p = 0.009), or between those from the MCF-7 and SKBR3 cells (p = 0.02) was confirmed with Students t test (Figure 3C ), confirming the effectiveness of dual labeling on the same EV for robust differentiation of the SKBR3-derived EVs from those produced by the MCF cells.T he EVs from MCF-7 and MCF-10A were not differentiable using these two markers, because the expression levels of both markers were comparable in these two EVs (Supporting Information, Figure S10 ).
Thes ignificant difference between the MFI values from different EV sub-populations indicates that our technique has the power to reveal the presence of EV sub-populations among heterogeneous mixtures.T oconfirm this,wetested the mixture of EVs from MCF-10A and SKBR3 prepared at a1:1 ratio.Using the distribution patterns identified with the pure EV populations,wecould clearly see the presence of two EV populations in the mixture ( Figure 3D ). Thep article count ratio for those locating within R1 and R3 was equal to 0.98 AE 0.07 (n = 3), agreeing with the mixing ratio of the two EV subpopulations.Incontrast, bulk analysis of the same EV mixture using ELISA only reflected as light increase in the HER2 content, but failed to recognize the presence of two distinct EV sub-populations (Supporting Information, Figure S10 ). More strikingly,v arying the mixing ratios of these two EV sub-populations,t he ratio of the particle counts in the gated regions of R1 and R3 showed as trongly linear relationship (R 2 = 0.9581) with the ratio of the added EV numbers between two cell lines (Supporting Information, Figure S13 ). These results demonstrate the great potential of our method in recognizing EV heterogeneity and differentiating EV subpopulations.
In summary,w eh ave developed as ingle-EV FCA technique to visualize individual EV in ac onventional flow cytometer for the first time,w hich can help gain in-depth insights into the molecular signatures of EV sub-populations under regular lab settings.W hile our work demonstrates simultaneous recognition of dual surface markers on the same vesicle,m ore markers can be targeted by simply revising the conformation-switchable probes to improve more effective differentiation of more EV sub-populations.F urthermore, our technique opens the opportunity for EV sorting and collection based on surface marker profiles under typical clinical lab settings.T he pure EV sub-populations obtained will definitely benefit clear correlation between EV composition and their biogenesis and functions.Overall, we believe this single-EV FCA technique is av aluable tool for gaining more understanding on the roles of EVs in cell-cell communication and pathological development, and its high simplicity and good adaptivity to clinical labs will be highly beneficial for screening for EV markers for liquid biopsy applications. Figure 3A using the EVsfrom the corresponding cell lines. The particle clusters were colored on the scatter plot of FSC vs. SSC and the histograms based on the gates defined in the HER2 vs. CD63 plots.
